| Noncanonical roles of chemokine regions in CCR9 activation revealed by structural modeling and mutational mapping | Nature communications |  | | 2025 | 5 | 4 |
|
| Arylsulfatases and neuraminidases modulate engagement of CCR5 by chemokines by removing key electrostatic interactions | Scientific reports | | | 2024 | 174 | 227 |
|
| Recombinant nanobodies detecting the human cardiac troponin proteins by ELISA | Antibody reports | | | 2023 | 63 | 371 |
|
| Precision-engineered peptide and protein analogs: establishing a new discovery platform for potent GPCR modulators | Chimia | | | 2021 | 239 | 165 |
|
| Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist | Science advances | | | 2021 | 271 | 520 |
|
| RB110 and RB157 antibodies recognize by ELISA specific phosphorylation patterns on CCR5 C-terminal peptides | Antibody Reports | | | 2020 | 350 | 196 |
|
| CCR5 tyrosine sulfation heterogeneity generates cell surface receptor subpopulations with different ligand binding properties | Biochimica et Biophysica Acta - General Subjects | | | 2020 | 315 | 272 |
|
| Rapid and low-cost multiplex synthesis of chemokine analogs | Journal of Biological Chemistry |  | | 2018 | 429 | 2 |
|
| δ-Conotoxins synthesized using an acid-cleavable solubility tag approach reveal key structural determinants for NaV subtype selectivity | The Journal of biological chemistry | | | 2014 | 685 | 1 |
|
| Identification, structural and pharmacological characterization of τ-CnVA, a conopeptide that selectively interacts with somatostatin sst3 receptor | Biochemical pharmacology | | | 2013 | 596 | 0 |
|
| Mechanism and molecular basis for the sodium channel subtype specificity of µ-conopeptide CnIIIC | British journal of pharmacology |  | | 2012 | 633 | 0 |
|
| A novel µ-conopeptide, CnIIIC, exerts potent and preferential inhibition of NaV1.2/1.4 channels and blocks neuronal nicotinic acetylcholine receptors | British journal of pharmacology | | | 2012 | 748 | 0 |
|
